NxStage Medical

NxStage Medical, Inc. is a medical technology company that develops, manufactures and markets innovative products for the treatment of end-stage renal disease (ESRD) and acute kidney failure. 
Its primary product includes the NxStage System One (the System One). NxStage operates in two segments: System One and In-Center. The Company markets the System One to hospitals for treatment of acute kidney failure and fluid overload. In addition to the System One, NxStage sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for patients with end-stage renal disease (ESRD). These products, which consist of Medisystems, include hemodialysis blood tubing sets, A.V. fistula needles and apheresis needles. The Company's blood tubing set products include the ReadySet High Performance Blood Tubing set (ReadySet), and the Streamline Airless Blood Tubing set (Streamline).

Type
Subsidiary
HQ
Lawrence, US
Founded
1998
NxStage Medical was founded in 1998 and is headquartered in Lawrence, US

NxStage Medical Office Locations

NxStage Medical has offices in Lawrence, Lutherville-Timonium, Wakefield, Norwood and in 44 other locations
Lawrence, US (HQ)
350 Merrimack St
Brunswick, US
1418 Town Center Blvd
Cincinnati, US
12065 Montgomery Rd
Lutherville-Timonium, US
h 1940 Greenspring Dr
Norwood, US
500 Providence Hwy
Wakefield, US
1 107 Audubon Rd
Show all (47)

NxStage Medical Financials and Metrics

NxStage Medical Summary

Founding Date

1998
NxStage Medical is a subsidiary of Fresenius Medical Care

NxStage Medical Financials

NxStage Medical's revenue was reported to be $366.4 m in FY, 2016
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

263.4 m301.5 m336.1 m366.4 m

Revenue growth, %

14%11%9%

Cost of goods sold

160.9 m185.6 m204.7 m214.4 m

Gross profit

102.5 m115.9 m131.5 m152 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

66.9 m72.2 m74.1 m75.3 m79.5 m80.3 m86.5 m89.2 m92.2 m92 m96.8 m96.2 m

Cost of goods sold

41.3 m43.3 m46.6 m46.7 m49.4 m49.5 m51.8 m52.7 m53.8 m52.8 m55.6 m55.1 m

Gross profit

25.5 m28.9 m27.5 m28.6 m30.1 m30.9 m34.7 m36.5 m38.4 m39.2 m41.2 m41.2 m

Gross profit Margin, %

38%40%37%38%38%38%40%41%42%43%43%43%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

84.1 m52.9 m59.1 m59.6 m

Accounts Receivable

20.2 m24.1 m25.2 m32.3 m

Inventories

4 m6.8 m6.3 m46.8 m

Current Assets

146.1 m129.2 m128.9 m144.9 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

83.2 m76.8 m62.1 m54.6 m51 m48.4 m51.3 m57.7 m58.5 m60.8 m55.5 m62.8 m

Accounts Receivable

22.5 m25.3 m31.1 m27.1 m24 m26.4 m30.6 m29.1 m30.1 m30.6 m39.3 m31.9 m

Inventories

37.1 m40.8 m43.4 m47.9 m45.3 m43.4 m42.6 m39 m41.3 m46.9 m48.5 m51.2 m

Current Assets

147.8 m147 m141.1 m134.4 m126.7 m124.4 m131.5 m131.7 m135.8 m144.2 m151.2 m155.5 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(18.6 m)(24.3 m)(16.3 m)(7.3 m)

Depreciation and Amortization

24.8 m27.7 m30.7 m32.6 m

Accounts Receivable

(1.1 m)(4.2 m)(1.1 m)(7.4 m)

Inventories

(20 m)(35 m)(12 m)(31.1 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(5 m)(5.3 m)(7.2 m)(6.8 m)(5.9 m)(5.6 m)(2 m)(1.8 m)(2.2 m)(890 k)(1.5 m)

Accounts Receivable

31.1 m27.1 m24 m26.4 m30.6 m29.1 m30.1 m30.6 m39.3 m

Inventories

43.4 m47.9 m45.3 m43.4 m42.6 m39 m41.3 m46.9 m48.5 m

Accounts Payable

22.5 m22.6 m17 m12.8 m12.8 m14.1 m13.6 m14.8 m18.5 m
Show all financial metrics

NxStage Medical Median Salaries

Source: 27 public H-1B filings from NxStage Medical

NxStage Medical's Web-traffic and Trends

NxStage Medical Online and Social Media Presence

NxStage Medical Company Life and Culture

You may also be interested in